Russia Reports First Case of Chikungunya Fever
(MENAFN) Russia confirmed its initial instance of Chikungunya fever on Friday, with the affected individual hospitalized in a stable but moderate condition, as detailed in a statement from the country's health monitoring agency, Rospotrebnadzor.
The agency noted that it had previously alerted the public to the potential threat of importing the illness from other countries.
As a result, medical professionals had been adequately prepared to respond to such an event.
As per the official statement, the infected patient had traveled to Moscow from Sri Lanka.
Upon arrival, the person sought medical care and was initially admitted to a specialized infectious diseases unit with a preliminary suspicion of dengue fever.
However, diagnostic tests later confirmed the presence of the chikungunya virus.
Despite this development, the risk of the disease spreading within Russia remains minimal. The virus is only transmitted through insect bites, and the species of mosquitoes responsible for its transmission are not present in sufficient numbers in Russia to pose a public health concern.
"Rospotrebnadzor promptly organized and carried out all necessary anti-epidemic measures," the agency emphasized.
According to the same source, border checkpoints across Russia are equipped with systems designed to detect travelers arriving from regions experiencing health crises, especially those exhibiting symptoms of infectious illnesses.
Chikungunya is characterized by symptoms such as high fever, intense joint and muscle pain, nausea, exhaustion, skin rashes, and joint swelling.
There is currently no approved vaccine or targeted medical therapy for this virus, the statement concluded.
The agency noted that it had previously alerted the public to the potential threat of importing the illness from other countries.
As a result, medical professionals had been adequately prepared to respond to such an event.
As per the official statement, the infected patient had traveled to Moscow from Sri Lanka.
Upon arrival, the person sought medical care and was initially admitted to a specialized infectious diseases unit with a preliminary suspicion of dengue fever.
However, diagnostic tests later confirmed the presence of the chikungunya virus.
Despite this development, the risk of the disease spreading within Russia remains minimal. The virus is only transmitted through insect bites, and the species of mosquitoes responsible for its transmission are not present in sufficient numbers in Russia to pose a public health concern.
"Rospotrebnadzor promptly organized and carried out all necessary anti-epidemic measures," the agency emphasized.
According to the same source, border checkpoints across Russia are equipped with systems designed to detect travelers arriving from regions experiencing health crises, especially those exhibiting symptoms of infectious illnesses.
Chikungunya is characterized by symptoms such as high fever, intense joint and muscle pain, nausea, exhaustion, skin rashes, and joint swelling.
There is currently no approved vaccine or targeted medical therapy for this virus, the statement concluded.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- What Is The Growth Rate Of The Europe Baby Food And Infant Formula Market In 2025?
- UK Digital Health Market To Reach USD 37.6 Billion By 2033
- Spycloud Launches Consumer Idlink Product To Empower Financial Institutions To Combat Fraud With Holistic Identity Intelligence
- Cryptogames Introduces Platform Enhancements Including Affiliate Program Changes
- What Does The Europe Cryptocurrency Market Report Reveal For 2025?
- Excellion Finance Launches MAX Yield: A Multi-Chain, Actively Managed Defi Strategy
Comments
No comment